Late morbidity and mortality in patients with hodgkin's lymphoma treated during adulthood

Journal of the National Cancer Institute

Volumn 107, Issue 4, 2015, Pages

  Matasar, Matthew J ^a,b   Ford, Jennifer S ^a   Riedel, Elyn R ^a   Salz, Talya ^a   Oeffinger, Kevin C ^a   Straus, David J ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULTHOOD; AGED; ANXIETY; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVOR; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DEPRESSION; DISABILITY; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; HEALTH SURVEY; HODGKIN DISEASE; HUMAN; LUNG DISEASE; MALE; MORBIDITY; PRIORITY JOURNAL; SECOND CANCER; CARDIOVASCULAR DISEASES; ENDOCRINE SYSTEM DISEASES; KAPLAN MEIER METHOD; LUNG DISEASES; MENTAL HEALTH; MIDDLE AGED; MORTALITY; NEOPLASMS, SECOND PRIMARY; ODDS RATIO; PREVALENCE; QUESTIONNAIRE; RISK; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; ENDOCRINE SYSTEM DISEASES; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG DISEASES; MALE; MENTAL HEALTH; MIDDLE AGED; MORBIDITY; NEOPLASMS, SECOND PRIMARY; ODDS RATIO; PREVALENCE; RISK; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 84930713303     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv018     Document Type: Article

References (58)

1. Meyer RM, Gospodarowicz MK, Connors JM, et al. ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma. N Engl J Med. 2012;366(5):399-408.
2. Engert A, Plutschow A, Eich HT, et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med. 2010;363(7):640-652.
3. Duggan DB, Petroni GR, Johnson JL, et al. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J Clin Oncol. 2003;21(4):607-614.
4. Engert A, Diehl V, Franklin J, et al. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study. J Clin Oncol. 2009;27(27):4548-4554.
5. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, et al. Long-term causespecific mortality of patients treated for Hodgkin's disease. J Clin Oncol. 2003;21(18):3431-3439.
6. Favier O, Heutte N, Stamatoullas-Bastard A, et al. Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials. Cancer. 2009;115(8):1680-1691.
7. Kiserud CE, Loge JH, Fossa A, et al. Mortality is persistently increased in Hodgkin's lymphoma survivors. Eur J Cancer. 2010;46(9):1632-1639.
8. Brusamolino E, Baio A, Orlandi E, et al. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up. Clin Cancer Res. 2006;12(21):6487-6493.
9. Ng AK, Bernardo MV, Weller E, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: longterm risks and risk factors. Blood. 2002;100(6):1989-1996.
10. van Leeuwen FE, Klokman WJ, Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol. 2000;18(3):487-497.
11. Swerdlow AJ, Higgins CD, Smith P, et al. Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study. J Clin Oncol. 2011;29(31):4096-4104.
12. Oeffinger KC, Bhatia S. Second primary cancers in survivors of childhood cancer. Lancet. 2009;374(9700):1484-1485.
13. Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 2007;109(5):1878-1886.
14. Galper SL, Yu JB, Mauch PM, et al. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood. 2011;117(2):412-418.
15. Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339.
16. Cella L, Conson M, Caterino M, et al. Thyroid V30 Predicts Radiation-Induced Hypothyroidism in Patients Treated With Sequential Chemo-Radiotherapy for Hodgkin's Lymphoma. Int J Radiat Oncol Biol Phys. 2012;82(5):1802-1808.
17. Hobbie WL, Ginsberg JP, Ogle SK, et al. Fertility in males treated for Hodgkins disease with COPP/ABV hybrid. Pediatr Blood Cancer. 2005;44(2):193-196.
18. Hodgson DC, Pintilie M, Gitterman L, et al. Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematol Oncol. 2007;25(1):11-15.
19. Ganz PA, Bower JE. Cancer related fatigue: a focus on breast cancer and Hodgkin's disease survivors. Acta Oncol. 2007;46(4):474-479.
20. Hjermstad MJ, Fossa SD, Oldervoll L, et al. Fatigue in long-term Hodgkin's Disease survivors: a follow-up study. J Clin Oncol. 2005;23(27):6587-6595.
21. Ng AK, Li S, Recklitis C, et al. A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigue. Ann Oncol. 2005;16(12):1949-1955.
22. Ruffer JU, Flechtner H, Tralls P, et al. Fatigue in long-term survivors of Hodgkin's lymphoma;a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer. 2003;39(15):2179-2186.
23. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572-1582.
24. Hudson MM, Mertens AC, Yasui Y, et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2003;290(12):1583-1592.
25. Castellino SM, Geiger AM, Mertens AC, et al. Morbidity and mortality in longterm survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood. 2011;117(6):1806-1816.
26. Ginsberg JP, Goodman P, Leisenring W, et al. Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study. J Natl Cancer Inst. 2010;102(16):1272-1283.
27. Armenian SH, Sun CL, Kawashima T, et al. Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood. 2011;118(5):1413-1420.
28. Hudson MM, Mulrooney DA, Bowers DC, et al. High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. J Clin Oncol. 2009;27(14):2405-2414.
29. Janeway KA, Grier HE. Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol. 2010;11(7):670-678.
30. Boman KK, Hoven E, Anclair M, et al. Health and persistent functional late effects in adult survivors of childhood CNS tumours: a population-based cohort study. Eur J Cancer. 2009;45(14):2552-2561.
31. Koziner B, Myers J, Cirrincione C, et al. Treatment of stages I and II hodgkin's disease with three different therapeutic modalities. Am J Med. 1986;80(6):1067-1078.
32. Straus DJ, Myers J, Lee BJ, et al. Treatment of advanced hodgkin's disease with chemotherapy and irradiation: Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations. Am J Med. 1984;76(2):270-278.
33. Straus DJ, Myers J, Passe S, et al. The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease. A follow-up report. Cancer. 1980;46(2):233-240.
34. Straus DJ, Portlock CS, Qin J, et al. Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) followed by radiation therapy (RT) vs ABVD alone for stages I, II and IIIA non bulky Hodgkin's disease. Blood. 2004;In press.
35. Straus DJ, Yahalom J, Gaynor J, et al. Four cycles of chemotherapy and regional radiation therapy for clinical early-stage and intermediate-stage Hodgkin's disease. Cancer. 1992;69(4):1052-1060.
36. Cella D. Manual of the functional assessment of chronic illness therapy (FACIT) scales, version 4. Evanston, IL: Center on Outcomes Research and Education, Evanston Northwestern Healthcare and Northwestern University 1997.
37. Northouse LL. Mastectomy patients and the fear of cancer recurrence. Cancer Nurs. 1981;4(3):213-220.
38. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica. 1983;67(6):361-370.
39. Ware Jr JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233.
40. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: Wiley;1980.
41. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer. cancer.gov) SEER Stat Database: Incidence-SEER 9 Regs Research Data, Nov 2011 Sub (1973-2010) -Linked To County Attributes-Total U.S., 1969-2010 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission.
42. Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996;334(12):745-751.
43. van Leeuwen FE, Klokman WJ, Stovall M, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst. 2003;95(13):971-980.
44. Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290(4):465-475.
45. Travis LB, Gospodarowicz M, Curtis RE, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst. 2002;94(3):182-192.
46. Taylor AJ, Croft AP, Palace AM, et al. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study. Int J Cancer. 2009;125(10):2400-2405.
47. Sigurdson AJ, Ronckers CM, Mertens AC, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet. 2005;365(9476):2014-2023.
48. Myrehaug S, Pintilie M, Tsang R, et al. Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy. Leuk Lymphoma. 2008;49(8):1486-1493.
49. Engert A, Pluetschow A, Eich HT, et al. Combined Modality Treatment of Two or Four Cycles of ABVD Followed by Involved Field Radiotherapy in the Treatment of Patients with Early Stage Hodgkin's Lymphoma: Update Interim Analysis of the Randomised HD10 Study of the German Hodgkin Study Group (GHSG). Blood. 2005;106(11):2673-2673.
50. Hodgson DC, Koh ES, Tran TH, et al. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma. Cancer. 2007;110(11):2576-2586.
51. Koh ES, Sun A, Tran TH, et al. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2006;66(1):223-228.
52. Schellong G, Riepenhausen M, Bruch C, et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer. 2010;55(6):1145-1152.
53. O'Brien MM, Donaldson SS, Balise RR, et al. Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. J Clin Oncol. 2010;28(7):1232-1239.
54. Copen CE, Daniels K, Vespa J, et al. First marriages in the United States: data from the 2006-2010 National Survey of Family Growth. Natl Health Stat Report. 2012;(49):1-21.
55. Zeltzer LK, Recklitis C, Buchbinder D, et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2396-2404.
56. Lash TL, Silliman RA. A comparison of the National Death Index and Social Security Administration databases to ascertain vital status. Epidemiology. 2001;12(2):259-261.
57. Sesso HD, Paffenbarger RS, Lee IM. Comparison of National Death Index and World Wide Web death searches. Am J Epidemiol. 2000;152(2):107-111.
58. German RR, Fink AK, Heron M, et al. The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol. 2011;35(2):126-131.